The application of engineering principles and problem-solving methodologies to biology and medicine is known as biomedical engineering. This is evident throughout healthcare, from diagnosis and analysis to treatment and recovery, and has made its way into the public consciousness through the proliferation of implantable medical devices like pacemakers and artificial hips, as well as more futuristic technologies like stem cell engineering and 3-D printing of biological organs. Biomedical engineering is concerned with technological advancements that improve human health and healthcare on a broad scale. Oncology, ontologies construction, genomics, genetic data, bio-mimetic systems, biomedical electronics, protein structure prediction, and biomedical data analysis are just a few of the fast growing uses of artificial intelligence and its applications in biomedical engineering. Intelligent agents are systems that operate perceptively: they do what they think is appropriate for the circumstance and purpose; they're flexible to changing environments and goals; they learn from experience; and they make appropriate choices given perceptual constraints and finite computing. Computational intelligence paradigms offer a number of advantages for keeping and improving the field of biomedical engineering. Furthermore, with the rapid improvements in computer-assisted operations and research in molecular, cellular, and tissue engineering, computational intelligence is becoming an indisputable aspect of biomedical applications.
This is to inform that due to some circumstances beyond the organizer control, “Euro Global Conference on Proteomics, Genomics and Bioinformatics” (Proteomics 2023) during September 18-20, 2023 at Valencia, Spain has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at proteomics@magnusconference.com or call +1 (702) 988 2320.
Title : Development of proteomic biomarkers in pancreatic cancer
Ru Chen, Baylor College of Medicine, United States
Title : Nutrition and proteomics: The need for N-of-1 experimental strategies
Jim Kaput, Vydiant, United States
Title : Discovering novel catalytic variants of peroxygenases and antioxidant enzymes in metagenomes and proteomoes from primeval forests in Middle Europe
Marcel Zamocky, Laboratory for Phylogenomic Ecology, Institute of Molecular Biology, Slovak Academy of Sciences, Slovakia (Slovak Republic)
Title : Crispr/Cas9 In Gossypium Hirsutum (Cotton) Coker 312 For Clcud Cotton Leaf Curl Virus Disease Resistance Mediated By Agrobacterium
Tahira Shafique, Fatima Jinnah College of Science and Commerce, Pakistan
Title : Analysis of data on behavioral characteristics of crazy people towards life in Indonesia, the vision of Indonesia being golden in 2045
Arman S Sos M Si, universitas ichsan Gorontalo, Indonesia
Title : The role of Gamma H2AX in apoptosis
Emmy Rogakou, University of Athens, Greece